Jehle-Kunz Sigrid, Häuselmann Hans-Jörg, Keschawarzi Mitra, Lamy Olivier, Luzuy Franck, Marcoli Natalie, Meier Christian, Uebelhart Brigitte, Wiedersheim Peter
Center for Osteoporosis, St. Anna Clinic, 6003 Lucerne, Switzerland.
Center for Rheumatology and Bone Diseases, 8038 Zurich, Switzerland.
Healthcare (Basel). 2022 Feb 3;10(2):295. doi: 10.3390/healthcare10020295.
Osteoporosis is the most common chronic metabolic bone disease, known to be underdiagnosed and undertreated in parts of the Swiss population. Due to expected rise in new fragility fractures, adequate awareness of associated risk factors and diagnostic and therapeutic options will be essential for the management of osteoporosis. We therefore explored these aspects in a nationwide survey of Swiss specialists and their patients. A total of 262 physician questionnaires and 9065 patient questionnaires were analyzed, mainly from general practitioners (64.9%), followed by rheumatologists (16.8%), gynecologists (12.2%), and endocrinologists (6.1%). Around 20% of patients were under medication and/or had a medical condition increasing the risk of osteoporosis. Further risk factors, such as low consumption of calcium-rich foods, smoking, elevated alcohol intake, and insufficient physical activity, were present across regions and medical fields. 53.9% of patients did not take calcium/vitamin D supplements; 3.5% reported having fragility fractures, and 7.3% received treatment for osteoporosis. Only 38.5% of surveyed patients knew of the chronic nature of osteoporosis, indicating rather low awareness in this population. Despite generally perceived relevance of osteoporosis for daily practice, aspects of its prevention and management varied across regions and medical fields. Raising awareness among patients and physicians will be vital for addressing osteoporosis on a national scale.
骨质疏松症是最常见的慢性代谢性骨病,在瑞士部分人群中存在诊断不足和治疗不足的情况。由于预计脆性骨折的新发病例将会增加,充分认识相关风险因素以及诊断和治疗选择对于骨质疏松症的管理至关重要。因此,我们在一项针对瑞士专家及其患者的全国性调查中探讨了这些方面。共分析了262份医生问卷和9065份患者问卷,主要来自全科医生(64.9%),其次是风湿病学家(16.8%)、妇科医生(12.2%)和内分泌学家(6.1%)。约20%的患者正在接受药物治疗和/或患有增加骨质疏松症风险的疾病。其他风险因素,如富含钙的食物摄入不足、吸烟、酒精摄入量增加和体育活动不足,在各个地区和医学领域都存在。53.9%的患者未服用钙/维生素D补充剂;3.5%的患者报告有脆性骨折,7.3%的患者接受了骨质疏松症治疗。只有38.5%的受访患者知道骨质疏松症的慢性性质,表明该人群的知晓率相当低。尽管普遍认为骨质疏松症与日常医疗实践相关,但其预防和管理在不同地区和医学领域存在差异。提高患者和医生的认识对于在全国范围内应对骨质疏松症至关重要。